Biotechnology instruments are medical equipment used in biotechnology and the related field of medical engineering, focusing on the application of engineering tools for scientific discovery and for the diagnosis and treatment of various disease. Moreover, the advancement in miniaturization and developing lightweight materials for constructing biotechnology instruments are providing new dimensions in designing these instruments.

Market Dynamics:

Rising in burden of chronic diseases, growing geriatric population, high demand for point-of-care (POC) tests/devices, increasing demand for IVD instruments, and high demand for biotechnology instruments are major factors expected to augment growth of the global biotechnology instruments market during the forecast period.

For instance, in May 2022, Agilent Technologies launched CE-IVD marked instruments, kits, and reagents as IVDR Class A, in compliance with the new EU IVDR regulation. This launch ensures that labs in the European Union (EU) who rely on Agilent IVDR instruments in their diagnostic workflows will continue to be able to use these products without disruption.

Moreover, in November 2021, Thermo Fisher Scientific launched new IVD system called Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR. The system is designed to support IVD testing and the development of assay menus.

Key features of the study:

• This report provides in-depth analysis of the global biotechnology instruments market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biotechnology instruments market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include AngioDynamics, Cynosure, LLC.., Lumenis, Candela Medical, Novanta, Inc., Iridex, Alcon, Inc., and Zimmer Biomet, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biotechnology instruments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biotechnology instruments market.

Detailed Segmentation:

• Global Biotechnology Instruments Market, By Product:
  • Lab Automation Instruments
    • Proteomics
    • Genomics
    • Sequencing
    • Spatial Cell Analysis
    • Others
  • Life Science Consumables
  • IVD Instruments
  • Medical Lasers
    • Therapeutics
    • Ophthalmics
    • Ablation
• Global Biotechnology Instruments Market, By End-Use:
  • Government & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Healthcare Facilities
  • Others
• Global Biotechnology Instruments Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • AngioDynamics
  • Cynosure, LLC.
  • Lumenis
  • Candela Medical
  • Novanta, Inc.
  • Iridex
  • Alcon, Inc.
  • Zimmer Biomet